# FDA Inspection 1277227 - Ultragenyx Pharmaceutical Inc. - July 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/328755e7-d412-4def-b423-f38d21b1a7b8
Source feed: FDA_Inspections

> FDA Inspection 1277227 for Ultragenyx Pharmaceutical Inc. on July 17, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277227
- Company Name: Ultragenyx Pharmaceutical Inc.
- Inspection Date: 2025-07-17
- Product Type: Human Drugs
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1277227 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/5630a73e-826a-4c90-b3a6-9bd1313a6920)
- [FDA Inspection 1199790 - 2023-02-27](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/44276fa6-30e1-4cba-89ea-213ede006e1f)
- [FDA Inspection 1015263 - 2017-06-20](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/d5c7d3c8-6d16-43a6-9227-06fd3ae78ce0)

Company: https://www.keypedia.com/companies/ultragenyx-pharmaceutical-inc/52e0a912-e566-4a1d-89b4-822a2feaf1d0

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df